Remove Competition Remove Government Remove Healthcare Provider
article thumbnail

Pharmacogenomics: Creating a Better Healthcare System

MedCity News

While current government and commercial efforts to negotiate competitive drug prices are important, this focus represents a minor—and misplaced—implementation of medication management. It’s time that policymakers, insurers and healthcare providers make pharmacogenomic testing a fundamental standard of care delivery.

article thumbnail

Marketing Pharma: Proven Strategies to Stay Ahead in a Competitive Industry

Pharma Marketing Network

Marketing pharma has become a complex and competitive field, with companies vying for the attention of healthcare providers (HCPs), patients, and regulators alike. With the right strategies, you can rise above the competition and drive measurable success. The good news?

article thumbnail

Generic Meds for Government Servants at IJN – Good News or Mixed Bag?

Contrarian Sales Techniques

When you hear that government servants in Malaysia will now be prescribed generic medications at Institut Jantung Negara (IJN), what’s your first thought? Malaysia’s Ministry of Health (MOH) recently made this decision to control rising healthcare costs. Is There Really a Big Difference? Skepticism? Will This Move Stick Around?

article thumbnail

Improving Access to Medicine: The Role of Pharma Companies in Emerging Markets

PM360

This can be especially important in the current global economic climate, where competition for market share is fierce, and access to new customers is critical for growth. This includes ensuring access and affordability of their products, which can positively impact their environmental social governance (ESG) score and reputation.

article thumbnail

10 Little-Known Facts About Medical Sales Jobs in Multinational Pharma Companies in Malaysia

Contrarian Sales Techniques

These companies are known for their innovation, global reach, and competitive perks. For instance, in Malaysia, success often requires understanding the dual healthcare system —balancing the needs of government hospitals, private institutions, and rural clinics. Pro Tip: Tailor your approach based on your territory.

article thumbnail

Biogen’s $900 million settlement signals scrutiny on speaker fees

Pharmaceutical Technology

Bringing an end to a 13-year deliberation on a whistleblower lawsuit, Biogen recently agreed to pay a $900 million settlement , amidst increased government alertness on pharmaceutical fraud. However, new MS drugs like Novartis ’ Gilenya, were going to soon enter the market and increase competition within the MS therapeutic landscape.

article thumbnail

10 Innovative Trends in Pharma Marketing: Strategies for Industry Success in 2025

Pharma Marketing Network

As we approach 2025, emerging trends are reshaping how the industry engages with patients and healthcare providers. With advancements in technology, increasing competition, and changing patient expectations, pharma marketers need to stay ahead of the curve. Patient-Centric Marketing Patients want to feel heard.